Page last updated: 2024-08-21

azomycin and aspirin

azomycin has been researched along with aspirin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Everett, SA; Naylor, MA; Patel, KB; Stratford, MR; Wardman, P1
Escanilla, S; Faúndez, M; Ferreira, A; Ferreira, J; Kemmerling, U; Klein, S; Lee-Liu, D; López-Muñoz, R; Maya, JD; Morello, A; Orellana, M; Torres, G1
Campos-Estrada, C; Carillo, I; Castillo, C; González-Herrera, F; Greif, G; Guzmán-Rivera, D; Kemmerling, U; Liempi, A; Maya, JD; Robello, C1
de Almeida Araújo, EJ; Lovo-Martins, MI; Lucchetti, BFC; Malvezi, AD; Martins-Pinge, MC; Pereira, RS; Pinge-Filho, P; Santos, JP; Tavares, ER; Verri, WA; Yamada-Ogatta, SF; Yamauchi, LM1

Other Studies

4 other study(ies) available for azomycin and aspirin

ArticleYear
Bioreductively-activated prodrugs for targeting hypoxic tissues: elimination of aspirin from 2-nitroimidazole derivatives.
    Bioorganic & medicinal chemistry letters, 1999, May-03, Volume: 9, Issue:9

    Topics: Animals; Aspirin; Bromides; Cell Hypoxia; Humans; Nitroimidazoles; Prodrugs; Salicylates; Time Factors

1999
Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole.
    Experimental parasitology, 2010, Volume: 124, Issue:2

    Topics: Animals; Aspirin; Cell Line; Cell Survival; Cyclooxygenase Inhibitors; Drug Synergism; Inhibitory Concentration 50; Macrophages; Mice; Nifurtimox; Nitric Oxide; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi

2010
Notch receptor expression in Trypanosoma cruzi-infected human umbilical vein endothelial cells treated with benznidazole or simvastatin revealed by microarray analysis.
    Cell biology international, 2020, Volume: 44, Issue:5

    Topics: Aspirin; Cells, Cultured; Chagas Disease; Gene Expression; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Nitroimidazoles; Receptor, Notch1; Simvastatin; Trypanosoma cruzi

2020
Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
    Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7

    Topics: Animals; Aspirin; Chagas Disease; Drug Combinations; Humans; Mice; Nitroimidazoles; Trypanocidal Agents; Trypanosoma cruzi

2020